Practical clinical trials for schizophrenia

Epidemiologia e Psichiatria Sociale

Volumn 14, Issue 3, 2005, Pages 132-136

  Stroup, Scott ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; FOLLOW UP; HEALTH CARE POLICY; HUMAN; QUALITY OF LIFE; SCHIZOPHRENIA; SOCIAL STATUS; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 27744499906     PISSN: 1121189X     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1121189X00006370     Document Type: Editorial

References (8)

1. Als-Nielsen B., Chen W., Gluud C. & Lise L. Kjaergard (2003). Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? Journal of American Medical Association 290, 921-928.
2. Essock S.M., Drake R.E., Frank R.G. & McGuire T.G. (2003). Randomized controlled trials in evidence-based mental health care: getting the right answer to the right question Schizophrenia Bulletin 29, 115-123.
3. Ioannidis J.P., Evans S.J., Gotzsche P.C., O'Neill R., Altman D.G., Schulz K. & Moher D. for the CONSORT Group (2004). Better reporting of harms in randomized trials: an extension of the CONSORT statement Annals of Internetional Medicine 141, 781-788.
4. Institute of Medicine (1985). Assessing Medical Technologies. National Academy Press: Washington, DC.
5. Moher D., Schulz K.F. & Altman D. (2001). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Journal of American Medical Association 285, 1987-1991.
6. Rosenheck R.A. (2005). Open forum: effectiveness versus efficacy of second-generation antipsychotics: haloperidol without anticholinergics as a comparator Psychiatric Services 56, 85-92.
7. Stroup T.S., McEvoy J.P., Swartz M.S., Byerly M.J., Click I.D., Canive J.M., McGee M.F., Simpson G.M., Stevens M.C. & Lieberman J.A. (2003). The NIMH-CATIE Project: Schizophrenia Trial Design and Protocol Development. Schizophrenia Bulletin 29(1), 15-31.
8. Tunis S.R., Stryer D.B. & Clancy C.M. (2003). Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. Journal of American Medical Association 290, 1624-1632.